Approval · Notice of Compliance 9709 · 2008
VEPESID: Notice of Compliance 9709
Issued August 12, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9709
- Date
- August 12, 2008
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antineoplastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VEPESID | 00616192 | Marketed |
Medicinal ingredients
- ETOPOSIDE 50 MG per CAP